Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance

Title
Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages 112190
Publisher
Elsevier BV
Online
2020-02-29
DOI
10.1016/j.ejmech.2020.112190

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started